How Are Biotechnology Firms Leveraging Artificial Intelligence in Cancer Research?
Artificial Intelligence (AI) is becoming an invaluable tool for biotechnology firms in cancer research. AI algorithms are used to analyze vast amounts of data from genomic studies, clinical trials, and medical records, identifying patterns and predicting treatment outcomes. This enables more accurate diagnosis, personalized treatment plans, and efficient drug discovery. Firms are also developing AI-powered platforms for predictive analytics and clinical decision support, enhancing the overall quality of cancer care.
